At the same time, in parallel to PI3K research by cancer biologists, studies using numerous PI3K-targeted therapies have revealed that the PI3K pathway contributes to a broad spectrum of human diseases including immune/inflammatory diseases, endocrine diseases, and cardiovascular diseases. This evidence concerns the gene PIK3CD and cardiovascular disorder.